Domo enables researchers to visualize complex data from experiments, clinical trials, and genomic studies, making it easier to identify patterns and draw meaningful conclusions. Dashboards can be shared across teams, facilitating collaboration between researchers, data scientists, and analysts for more integrated insights.

Domo allows for the visualization of clinical trial data, including patient recruitment, trial progress, and adverse events, enabling timely decision-making and adjustments. By analyzing historical clinical trial data, biotech companies can forecast outcomes, optimize trial designs, and improve patient selection strategies.

Domo helps biotech firms visualize data quality metrics, ensuring compliance with regulatory standards (e.g., FDA regulations) and maintaining data integrity. Automated dashboards can simplify regulatory reporting processes, providing clear and compliant visual representations of necessary data.

Biotech companies can track key performance indicators (KPIs) related to R&D productivity, project timelines, and resource allocation, helping to optimize operations and reduce costs. Visualization of resource utilization (laboratory equipment, personnel, funding) assists in better planning and allocation.

Domo can analyze market data, competitor activities, and customer insights, helping biotech companies identify opportunities for new products and services. By visualizing sales data and marketing campaign performance, companies can refine their strategies and improve customer engagement.

Domo integrates data from various sources (e.g., laboratory information systems, clinical databases, financial data), providing a comprehensive view of operations and research. The intuitive drag-and-drop interface allows non-technical users to create their own visualizations and dashboards, democratizing data access across teams.